QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2017-05-10
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- NantPharma, LLC
- Registration Number
- NCT03147976
- Locations
- 🇺🇸
Chan Soon-Shiong Institute for Medicine, El Segundo, California, United States
QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma
- First Posted Date
- 2017-04-27
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- NantPharma, LLC
- Target Recruit Count
- 8
- Registration Number
- NCT03132155
- Locations
- 🇺🇸
The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Chan Soon-Shiong Institute for Medicine, El Segundo, California, United States
QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer
Phase 1
Withdrawn
- Conditions
- Pancreatic Adenocarcinoma Metastatic
- Interventions
- Drug: Eloxatin Injectable Product
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- NantPharma, LLC
- Registration Number
- NCT03127124
- Locations
- 🇺🇸
Chan Soon-Shiong Institutes for Medicine, El Segundo, California, United States
© Copyright 2025. All Rights Reserved by MedPath